Noble Biomaterials

About:

Noble is a producer of silver-based advanced material technologies designed for mission-critical applications.

Website: http://noblebiomaterials.com

Twitter/X: noble_advantage

Top Investors: Ben Franklin Technology Partners of Northeastern Pennsylvania, DuPont Capital Management, Rittenhouse Ventures, TL Ventures, Northwater Capital

Description:

Noble Biomaterials is a global leader in antimicrobial and conductivity solutions for soft surface applications. They supply medical components to the US military, and a US EPA–registered antimicrobial manufacturer.

Total Funding Amount:

$8.03M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Scranton, Pennsylvania, United States

Founded Date:

1997-01-01

Contact Email:

info(AT)x-static.com

Founders:

Joel Furey

Number of Employees:

101-250

Last Funding Date:

2020-06-23

IPO Status:

Private

Industries:

© 2025 bioDAO.ai